Coherentmarketinsightsus

    Positron Emission Tomography (PET) is a clinical imaging technology found in the diagnosis of numerous diseases such as cancer and Alzheimer's disease. The basic principle of PET imaging involves the detection of a set of gamma rays emitted indirectly by way of a radiotracer. PET may also distinguish between non-malignant tumors and malignant tumors. Major players operating in the global Positron Emission Tomography (PET) Scanners Market include, GE Healthcare, Toshiba Corporation, Koninklijke Philips N.V., Siemens Healthineers, Hitachi Medical Corporation, Positron Corporation, Mediso Ltd., and Yangzhou Kindsway Biotech Co., Ltd. Positron Emission Tomography (PET) scan is an MRI study that helps to find out how your tissues and organs are working. Because of this operation, a PET scan utilizes a radioactive medicine (tracer). Sometimes this test can identify diseases before it appears in other MRI exams. With respect to the organ or tissue researched,...